143 related articles for article (PubMed ID: 22430137)
1. Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma.
Chung K; Nishiyama N; Yamano S; Komatsu H; Hanada S; Wei M; Wanibuchi H; Suehiro S; Kakehashi A
Cancer Biomark; 2011-2012; 10(2):101-7. PubMed ID: 22430137
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
[TBL] [Abstract][Full Text] [Related]
4. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
[TBL] [Abstract][Full Text] [Related]
5. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L
Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
[TBL] [Abstract][Full Text] [Related]
8. Serum AGR2 as a useful biomarker for pituitary adenomas.
Tohti M; Li J; Tang C; Wen G; Abdujilil A; Yizim P; Ma C
Clin Neurol Neurosurg; 2017 Mar; 154():19-22. PubMed ID: 28092730
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
10. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
11. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
12. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
13. Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.
Yamashita S; Tokuishi K; Moroga T; Yamamoto S; Ohbo K; Miyahara S; Yoshida Y; Yanagisawa J; Hamatake D; Hiratsuka M; Yoshinaga Y; Shiraishi T; Iwasaki A; Kawahara K
Tumour Biol; 2012 Dec; 33(6):2365-70. PubMed ID: 23001907
[TBL] [Abstract][Full Text] [Related]
14. Expression of AGR2 in non small cell lung cancer.
Fritzsche FR; Dahl E; Dankof A; Burkhardt M; Pahl S; Petersen I; Dietel M; Kristiansen G
Histol Histopathol; 2007 Jul; 22(7):703-8. PubMed ID: 17455144
[TBL] [Abstract][Full Text] [Related]
15. Serum HE4 as a diagnostic and prognostic marker for lung cancer.
Iwahori K; Suzuki H; Kishi Y; Fujii Y; Uehara R; Okamoto N; Kobayashi M; Hirashima T; Kawase I; Naka T
Tumour Biol; 2012 Aug; 33(4):1141-9. PubMed ID: 22373583
[TBL] [Abstract][Full Text] [Related]
16. High expression of AGR2 in lung cancer is predictive of poor survival.
Alavi M; Mah V; Maresh EL; Bagryanova L; Horvath S; Chia D; Goodglick L; Liu AY
BMC Cancer; 2015 Oct; 15():655. PubMed ID: 26445321
[TBL] [Abstract][Full Text] [Related]
17. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
[TBL] [Abstract][Full Text] [Related]
18. AGR2 as a potential biomarker of human lung adenocarcinoma.
Chung K; Nishiyama N; Wanibuchi H; Yamano S; Hanada S; Wei M; Suehiro S; Kakehashi A
Osaka City Med J; 2012 Jun; 58(1):13-24. PubMed ID: 23094510
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
[TBL] [Abstract][Full Text] [Related]
20. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]